References:
- Herman P, Fonseca GM, Kruger JAP, Jeismann VB, Coelho FF. Guidelines
for the Treatment of Hepatocellular Adenoma in the Era of Molecular
Biology: An Experience-Based Surgeons’ Perspective. J Gastrointest
Surg 2021;25(6):1494-502.
- Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler A, Orgill DP, For the
SCARE Group. The SCARE 2018 Statement: Updating Consensus Surgical
CAse REport (SCARE) Guidelines. Int J Surg 2018;60:132-6.
- Fukayama M, Paradis V, Park YN, Schirmacher P. WHO Classification of
Tumours of the Digestive System. 8. Tumours of the liver and
intrahepatic bile ducts. Fifth ed. Geneva: World Health Organization;
2019.
- European Association for the Study of the Liver. EASL Clinical
Practice Guidelines on the management of benign liver tumours. J
Hepatol 2016;65:386-98.
- Mounajjed T. Hepatocellular adenoma and Focal nodular Hyperplasia.
Clin liver Dis 2021;17(4):244-8.
- Neves Sousaa CM, de Sousa Cartaxoa R, Schuler Honorio R,
Rêgo Coelhod G, Rêgo Coelhoa C, Miranda Gadelhaa PM, et al. Hepatocyte
Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical
Presentation. Case Rep Gastroenterol 2017;11:637-42.
- Vincenzo K. Wong VK, Fung AW, Elsayes KM. Magnetic resonance imaging
of Hepatic adenoma subtypes. Clin liver Dis 2021;17(3):113-8.
- Wong VK, Fung AW, Elsayes KM. Magnetic resonance imaging of Hepatic
adenoma subtypes. Clin liver Dis 2021;17(3):113-8.
- Beaufrère A, Paradis V. Hepatocellular adenomas: review of
pathological and molecular features. Hum Pathol 2020.https://doi.org/10.1016/j.
humpath.2020.11.016.
- Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of
hepatocellular adenomas: impact on clinical practice. Hepat Oncol
2018;5(1):HEP04.
- Garcia-Buitrago MT. Advances in hepatology. Gastroenter Hepatol
2017;13(12):740-3.
- Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra
V, et al. Diagnostic accuracy of MRI in differentiating hepatocellular
adenoma from focal nodular hyperplasia: prospective study of the
additional value of gadoxetate disodium. AJR 2012;199:26-34.
- Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M,
Müller T, Bläker H, Seehofer D, Denecke T. Hepatocellular adenomas: is
there additional value in using Gd-EOB-enhanced MRI for subtype
differentiation? Eur Radiol 2020;30:3497-506.
- van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular ade-
nomas: correlation of MR imaging findings with pathologic subtype
classification. Radiology 2011;261:172-81.
- Koya Y, Suzuki T, Tai M, Ichii O, Matsuhashi N, Ejiri Y, et al.
Inflammatory Hepatocellular Adenoma with Elevated Serum Protein
Induced by Vitamin K Absence/Antagonist-II in Adult Males. Intern Med
2019;58:1739-46.
- Hoshino K, Harimoto N, Muranushi R, Hagiwara K, Yamanaka T, Ishii N,
et al. Unclassified hepatocellular adenoma with histological brown
pigment deposition and serum PIVKA-II level elevation: a case report.
Surg Case Rep 2020;6:94.
- Fodor M, Primavesi F, Braunwarth E, Cardini B, Resch T, Bale R, et al.
Indications for liver surgery in benign tumours. Eur Surg
2018;50:125-31.
- Kim SM, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al.
Clinicopathological features and post-resection outcomes of
hepatocellular adenoma. Ann Hepatobiliary Pancreat Surg 2021;25:25-33.
- van Rosmalen BV, Klompenhouwer AJ, Jaap de Graeff J, Haring MDP, de
Meijer VE, Rifai L, et al. Safety and efficacy of transarterial
embolization of hepatocellular adenomas. BJS 2019;106:1362-71.